Trials / Completed
CompletedNCT01089400
Immuno-virological Characterization of Severe H1N1v Influenza Infection in Bronchoalveolar Lavage
Immuno-virological Characterization of Severe H1N1v Influenza Infection in Bronchoalveolar Lavage in Patients Requiring Mechanical Ventilation in Intensive Care Unit
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (actual)
- Sponsor
- Institut National de la Santé Et de la Recherche Médicale, France · Other Government
- Sex
- All
- Age
- 13 Years
- Healthy volunteers
- Not accepted
Summary
The influenza A/H1N1v pandemic virus causes severe pneumonia that can lead to acute respiratory distress syndrome and death even in healthy young individuals. The respective roles of viral replication, bacterial infection and immune alterations of the host during such severe influenza H1N1v infection need to be clarified in order to optimize patients care. In this context, we aim to study immune and virological parameters in bronchoalveolar lavage fluid during severe influenza A/H1N1v infection with pulmonary involvement in intensive care unit. Results will be correlated to bacterial or viral pulmonary co-infections and to peripheral blood immune and virological parameters.
Conditions
Timeline
- Start date
- 2009-10-01
- Primary completion
- 2011-04-01
- Completion
- 2011-04-01
- First posted
- 2010-03-18
- Last updated
- 2025-12-04
Locations
2 sites across 1 country: France
Source: ClinicalTrials.gov record NCT01089400. Inclusion in this directory is not an endorsement.